Introduction
The periosteum covers almost the entire bone surface and is one of the most regenerative tissues for skeletal osteogenesis (1) . Damage to the periosteum severely impairs cortical bone homeostasis (2) . The periosteum consists of 2 layers: the inner layer on the periosteal surface with monocyte/macrophage-lineage cells, such as tartrate-resistant acid phosphatase-positive (TRAP + ) mononuclear cells, osteoblastic cells, and abundant periostin and the outer layer, which is packed tightly with collagens, blood vessels, and nerve endings (3) (4) (5) (6) . Periosteum-derived cells (PDCs), also called periosteum-derived multipotent mesenchymal stromal cells (MSCs) (7) , periosteal progenitor cells (8) , or periosteum-derived stem cells (9) , reside distal to the periosteal bone surface and are believed to contain periosteal stem cells (PSCs) that continuously give rise to osteoblasts for osteogenesis (10, 11) . A recent study identified a PSC in the long bones and calvarium of mice (12) . The periosteum provides a microenvironment that nourishes PDCs to allow underlying periosteal bone formation (13) , and periostin is involved in the regulation of periosteum homeostasis (14) . PDCs proliferate rapidly and differentiate into various types of cells to support healing after bone fracture (15) . This impressive bone regenerative ability of the periosteum has prompted extensive research into the use of PDCs for bone regenerative applications (16) (17) (18) .
In vitro single-cell lineage analysis has shown that PDCs have mesenchymal multipotency (osteogenic, chondrogenic, adipogenic, and myogenic) at the clonal level and that expanded PDCs can form bone, cartilage, and hematopoietic marrow when transplanted in vivo (19) (20) (21) . Periosteal cells retain high growth potency and differentiation capability even in elderly patients (22) . However, periosteal cell cultures have indicated the heterogeneous nature of PDCs with MSCs, fibroblasts, and osteogenic cells (7) . Recently, Chan et al. determined that PDPN +
CD146
-CD73 + CD164 + expression marks a self-renewing, multipotent human skeletal stem cell, which also resides in the periosteum (23 
CD105
-cells in the periosteum are periosteal mesenchymal stem cells (12) . These findings indicate that cell markers are essential to characterize the potential stem cell nature of PDCs, which may contain different subpopulations and likely have roles during cortical bone formation and regeneration. MSC activities are progressively enriched in a subset of Nestin + cells during postnatal life, and Nestin + PDGFR-α + cells are more similar to primitive bone marrow mesenchymal stromal cells (BMSCs) and are distinct from more differentiated osteoblastic cells (24, 25) . Nestin + cells are abundant in perichondrium, which become the early stage of periosteum during embryonic endochondral ossification (26) . Moreover, LepR + cells, a major subpopulation of MSCs involved in osteogenesis in adults, are very active in response to irradiation or fracture (27, 28) . Nestin + cells and LepR + cells in the periosteum may
Cortical bones account for more than 80% of human bone mass. The periosteum, a thin tissue that covers almost the entire bone surface, is essential for bone formation and regeneration. However, its osteogenic and bone regenerative abilities are not well studied. In this study, we found that macrophage-lineage cells recruit periosteum-derived cells (PDCs) for cortical bone formation. Knockout of colony-stimulating factor-1 eliminated macrophage-lineage cells and resulted in loss of PDCs with impaired periosteal bone formation. Moreover, macrophage-lineage tartrate-resistant acid phosphatase-positive (TRAP + ) cells induced transcriptional expression of periostin and recruitment of PDCs to the periosteal surface through secretion of PDGF-BB, where the recruited PDCs underwent osteoblast differentiation coupled with type H vessel formation. We also found that subsets of Nestin + and LepR
CD31
-cells (LepR + PDCs) possess multipotent and self-renewal abilities and contribute to cortical bone formation. Nestin + PDCs are found primarily during bone development, whereas LepR + PDCs are essential for bone homeostasis in adult mice. Importantly, conditional knockout of Pdgfr-β in LepR + cells impaired periosteal bone formation and regeneration. These findings uncover the essential role of periosteal macrophage-lineage cells in regulating periosteum homeostasis and regeneration.
Macrophage-lineage TRAP + cells recruit periosteumderived cells for periosteal osteogenesis and regeneration adjacent to the periosteal bone surface with type H (CD31 hi Emcn hi ) vessels during cortical bone growth and diminished during late adulthood ( Figure 1 , C, D, M, and N), suggesting an osteogenic environment at the periosteal surface. The cellularity in the periosteum was seen largely on the periosteal surface and increased continuously until early adulthood, then decreased during late adulthood ( Figure  1 , E, O, and P). Nevertheless, the large area of periosteum distal to the periosteal surface has far fewer cells, with no periostin or type H vessels and is clearly distinct from the inner layer ( Figure 1, C 
Ter119
-CD31 -cells was 0.64% ± 0.11% among all sorted periosteal cells in 1-month-old Nestin-GFP + mice and decreased significantly to 0.03% ± 0.01% in 3-month-old mice (Supplemental Figure 1A ; supplemental material available online with this article; https://doi. org/10.1172/JCI98857DS1). Moreover, 5.4% ± 1.6% of Nestin + PDCs were positive for LepR in 1-month-old mice, and 9.6% ± 3.5% were positive for LepR in 3-month-old mice, indicating 2 subpopulations of PDCs (Supplemental Figure 1B) . It was interesting to note Nestin + PDCs were 88% ± 3.1% and 93% ± 3.4% positive for MSC markers PDGFR-α and PDGFR-β, respectively (Supplemental Figure  1C) Figure 1D) . Moreover, Nestin + PDGFR-α + PDCs were highly positive for MSC markers CD90 (81% ± 5.7%) and CD105 (80% ± 3.9%), whereas only 20% ± 3.7% and 20% ± 2.3% of Nestin-GFP  + PDGFR-α  -CD45   -Ter119   -CD31 -cells were positive for these markers, respectively, suggesting that periosteal Nestin-GFP + cells contain PDGFR-α + stem/progenitor cells and PDGFR-α -cells (Supplemental Figure 1 , E-H). In a similar experiment using LepR-cre R26R-EYFP mice, we found that periosteal LepR + PDC cells were relatively scarce in 1-month-old mice (0.02% ± 0.01%) and significantly increased in 3-month-old mice (0.52% ± 0.31%), in contrast to Nestin-GFP + PDCs (Supplemental Figure 1I ). LepR + PDCs were 94% ± 1.2% and 94% ± 2.5% positive for MSC markers PDGFR-α and PDGFR-β, respectively (Supplemental Figure 1J) . Remarkably, nearly 93% of PDGFR-α + CD45 -
-CD31 -cells were LepR + (Supplemental Figure 1K ). Meanwhile, nearly 83% and 78% of LepR + PDCs were also highly positive for MSC markers CD90 and CD105, respec tively, suggesting that these periosteal cells might be highly enriched for MSCs (Supplemental Figure 1, L-N) .
To assess the colony-forming unit-fibroblast (CFU-F) activity, we sorted and expanded different subpopulations of periosteal cells and added them to adherent cultures at clonal density. Results showed the percentage of cells in each cell population sorted from CD45 -
-CD31 -periosteal cells that formed CFU-Fs in culture.
be subsets of PDCs that are responsible for periosteal bone formation. It is imperative to understand how PDCs are involved in the regulation of skeletal osteogenesis and maintaining the periosteum microenvironment.
The periosteum contains cells responsible for cortical bone growth, modeling, remodeling, and bone fracture healing (29, 30) . Cortical bone is compact, constituting the "shell" that covers the trabecular bone of vertebrae and long bones (31) (32) (33) . Cortical bone represents 80% of human bone mass and provides mechanical support of the body and protects vital organs (34) . In contrast, the spongy interior trabecular bone that constitutes the remaining 20% of skeletal mass undergoes constant remodeling, primarily for mineral metabolism (35) . Our knowledge of bone metabolism and remodeling is based predominantly on the study of trabecular bone. The contribution of cortical bone for peak bone mass is substantial, however, and the risk of bone fracture depends mainly on cortical bone density and strength (30, 36, 37) . We have limited understanding of the mechanism of cortical bone formation and homeostasis.
Knockout of macrophage colony-stimulating factor-1 (Csf1 -/-) leads to the depletion of mononuclear phagocytes, including macrophages and TRAP + cells, and to markedly impaired cortical bone formation (4, 38) . Resident macrophages present in various tissues regulate the microenvironment for homeostasis and regeneration (39) (40) (41) . Although the function of TRAP + cells is bone resorption, recent studies have shown that TRAP + cells are signalinginitiated cells that modulate the niche in which they reside (42, 43) . We have previously shown that TRAP + mononuclear cells secrete PDGF-BB to recruit MSCs for osteogenesis, coupled with angiogenesis (4). We have also determined that TRAP + cells secrete NETRIN-1 to induce sensory nerve axonal growth in subchondral bone (44) . Moreover, we found that the TRAP + cell-mediated release of TGF-β not only induces MSC but also induces the initial pathological changes of enthesopathy (45, 46) .
In this study, we investigated the role of periosteal macrophage-lineage cells, particularly TRAP + mononuclear cells, in maintaining periosteum homeostasis and regulating PDC differentiation for periosteal bone formation. We found that subsets of periosteal Nestin + and LepR + cells have the potential to give rise to osteoblasts for periosteal bone formation. Resident macrophage-lineage cells maintain periosteum homeostasis, and TRAP + mononuclear cells recruit PDCs to the periosteal osteogenic microenvironment for bone formation and regeneration.
Results

Nestin
+ and LepR + PDCs are located in the outer layer of the periosteal surface. To understand the potential role of PDCs, along with abundant matrix proteins and blood vessels in the periosteum to promote cortical bone formation, we performed immunostaining of longitudinal periosteal sections of the tibiae of mice from early postnatal to late adulthood. We found that TRAP + mononuclear cells were abundant on the periosteal bone surface in young mice and decreased markedly during late adulthood (Figure 1 , A, B, and F), whereas few TRAP + mononuclear cells resided on the endosteal bone surface (Figure 1, A, B , and G). We found very few TRAP + multinuclear cells on the surface of cortical bone during the early postnatal period, and the cell numbers gradually increased during adulthood ( Figure 1H ). Notably, periostin was expressed abundantly jci.org Volume 129 Number 6 June 2019
Next, CFU-Fs derived from Nestin + PDGFR-α + and LepR + PDCs were injected into the femora of 1-month-old NOD SCID mice at a density of 1 × 10 6 to measure their in vivo self-renewing ability ( Figure 2, A and B) . GFP + or YFP + cells from the bone marrow were collected by FACS 8 weeks after injection and plated for CFU-F formation. The colonies were expanded and retransplanted into the femora of recipient mice for the second round of in vivo self-renewal assay. Importantly, all colonies generated by the secondary CFU-Fs still highly expressed CD90 (80% ± 2.5% from Nestin Figure 1O ). We then measured and compared the self-renewal and multidifferential potency between PDCs and BMSCs by using FACS Nestin osteocytes derived from Nestin + lineage cells compared with vehicle control (Supplemental Figure 8F) . As a result, periosteal bone thickness, the periosteum perimeter, and trabecular bone volume and thickness were significantly increased in Ctsk -/-mice (Supplemental Figure 8G ). Osx + osteoprogenitors and CD31
hi Emcn hi vessels, in addition to the cellularity of the inner layer of periosteum, were significantly increased, whereas the thickness of the inner layer of periosteum was not significantly increased (Supplemental Figure 8 , H-K), indicating that the periosteum thickness was maintained as in the physiological condition. These results show that PDGF-BB secreted by TRAP + mononuclear cells is essential for the recruitment of Nestin + and LepR + PDCs to the periosteal bone surface for bone formation and periosteum homeostasis.
Transcriptional expression of periostin by PDGF-BB generates an osteogenic microenvironment at the periosteal surface layer. The osteogenic microenvironment of the periosteum is essential for periosteal bone formation (49) . We then examined whether PDGF-BB secreted by TRAP + mononuclear cells regulates the periosteal osteogenic microenvironment. Conditional ablation of PDGF-BB in macrophage-lineage TRAP + cells significantly reduced expression of periostin in periosteum, and an increase of PDGF-BB in Ctsk -/-mice significantly upregulated periostin expression ( Figure 6 , A and B), suggesting that PDGF-BB induces the periosteal osteogenic microenvironment on the periosteal surface by modulating periostin expression. Previous studies showed that periostin is expressed primarily in osteoblastic cells and is a novel marker for intramembranous ossification (50) (51) (52) . To examine the molecular mechanism of PDGF-BB-induced periostin expression, we sorted Nestin + PDGFR-α + PDCs by FACS. Western blot and RT-PCR showed almost no detectable periostin mRNA and protein expression in PDCs. However, periostin was expressed primarily in PDC-induced osteoblasts, and PDGF-BB further promoted periostin expression in a time-and dosedependent manner ( Figure 6 , C-E). We further elucidated the signaling mechanism of PDGF-BB-induced periostin upregulation. Western blot analysis showed that PDGF-BB induced the phosphorylation of PDGFR-β, phosphoinositide 3-kinase (PI3K), AKT, and cAMP-response element binding protein (CREB) 10 minutes after treatment and reached a peak at 30 minutes ( Figure 6F ), which was further confirmed by immunostaining ( Figure 6G ). Moreover, independent inhibition of PDGFR-β, PI3K, AKT, and CREB was sufficient to block the upregulation of periostin (Figure 6H ), indicating that PDGF-BB induces periostin expression via the PDGFR-β/PI3K/AKT/CREB signaling pathway. To test whether PDGF-BB transcriptionally activates periostin expression, we analyzed potential binding of phosphorylation of CREB (pCREB) to periostin promoter in ChIP assays. PDGF-BB induced direct binding of pCREB to periostin promoter (Frag 2) ( In contrast, knockout of Pdgfr-β in LepR + cells showed that LepR + PDCs contribute to periosteal bone formation mainly in adult mice. Specifically, the recruitment of LepR + cells to the periosteal surface was significantly impaired (Figure 8, A, B , and D) in 3-month-old mice relative to control littermates, whereas the total number ( Figure 8D ) and proliferation were not significantly decreased (Figure 8, E and F) . Knockout of Pdgfr-β in LepR + cells itself did not promote PDC migration (Supplemental Figure 9 , A and B). Periostin promoted osteogenesis of PDCs (10 μg/ml) in Alizarin red staining (Supplemental Figure 9 , C and D) and adhesion (Supplemental Figure 9 , E and F) of PDCs (1 μg/ml) in a dose-dependent manner. Thus, although PDGF-BB recruits PDCs to the periosteal bone surface, it also induces periostin secretion to generate a periosteal osteogenic microenvironment for differentiation and adhesion of PDCs. (Figure 7A ), whereas the total number ( Figure 7C ) and proliferation ( Figure 7 , E and F) of periosteal Nestin + cells were not osteoblast differentiation, coupled with type H vessel formation (Supplemental Figure 12B) Although remodeling of trabecular bone occurs in the bone marrow microenvironment, growth and modeling of cortical bone take place in the periosteum, which covers the outer surface of cortical bone. In young bones, the periosteum is thick with rich vascular supply, but later in life, it is thinner with less vascularity. Bones that lose the periosteum secondary to injury or disease usually scale or die. During growth or modeling, periosteal cortical bone formation, in coordination with endocortical bone resorption, leads to the expansion in diameter of the long bones. Periosteal expansion of cortical bone can substantially increase bone strength, independent of bone mass density. The periosteum provides a supportive microenvironment with vasculature, nerves, PDCs, and osteoprogenitors, which resembles a unique bone marrow for the growth and modeling of cortical bone. A recent study showed that PSCs are present in the long bones and calvarium and display clonal multipotency and self-renewal ability distinct from those of other skeletal stem cells and mature mesenchymal cells (12) . Duchamp de Lageneste et al. also showed that the periosteum contains skeletal stem cells with high bone regenerative potential relative to bone marrow stromal cells/skeletal stem cells (14) . Colnot et al. investigated periosteal Prx1 + cells and showed that periostin is required to maintain the pool of periosteum skeleton stem cells and that lack of periostin impairs periosteum function and bone healing (14) . We found that macrophage/monocytes differentiate into periosteal TRAP + mononuclear cells during bone growth and secrete PDGF-BB, which transcriptionally induces expression of periostin to generate an osteogenic 
Conditional knockout of Pdgfr-β in Nestin
Discussion
Periosteum provides an essential environment for cortical bone growth, bone modeling, and fracture healing (29, 30) . Although great effort has been made to investigate the mechanism of periosteal bone formation (1, 2, 13), we still know little about the osteogenic nature of the periosteum and how PDCs are maintained to regulate cortical bone formation and bone regeneration. In this study, we found a mechanism in which periosteal macrophagelineage cells regulate the periosteum osteogenic microenvironment for cortical bone formation and regeneration. Moreover, TRAP + cells induce transcriptional expression of periostin and recruit PDCs to the periosteal surface. The recruited PDCs undergo 
) to TRAP-cre iDTR and iDTR mice (as a control).
Ctsk -/-offspring and their WT littermates were generated by crossing 2 heterozygote strains as previously described (58) . We analyzed male mice at 1 month of age, except as noted in specific experiments. To induce Cre recombinase activity, we injected mice at designated time points with tamoxifen (100 mg/kg BW). The genotypes of the mice were determined by PCR analyses of genomic DNA extracted from mouse tail snips using the following primers: Csf1 op allele forward, 5′-TGCTAACCTCGTGGTTCCTG-3′ and reverse, 5′-GTTAGCATTG-GGGGTGTTGT-3′; TRAP-cre forward, 5′-ATATCTCACGTACTGAC-GGTGGG-3′ and reverse, 5′-CTGTTTCACTATCCAGGTTACGG-3′; loxP Pdgfb allele forward, 5′-GGGTGGGACTTTGGTGTAGAGAAG-3′ and reverse, 5′-GGAACGGATTTTGGAGGTAGTGTC-3′; Ctsk forward, 5′-GCCACACCCACACCCTAGAAG-3′ and reverse, 5′-ACAAGTGTA-CATTCCCGTACC-3′; Nestin-cre forward, 5′-GCG GTC TGG CAG TAA AAA CTA TC-3′ and reverse, 5′-GTG AAA CAG CAT TGC TGT CAC TT-3′; Nestin-GFP allele forward, 5′-GGA GCT GCA CAC AAC CCA TTG CC-3′ and reverse, 5′-GAT CAC TCT CGG CAT GGA CGA GC-3′; LepR-cre forward, 5′-CTT GGG TGG AGA GGC TAT TC-3′ and reverse, 5′-AGG TGA GAT GAC AGG AGA TC-3′; loxP Pdgfr-β allele forward, 5′-CCA GTT AGT CCA CTT ATG TTG-3′ and reverse, 5′-TAC CAG GAA GGC TTG GGA AG-3′; Dmp1-cre forward, 5′-CCCGCAGAACCT-GAAGATG-3′ and reverse, 5′-GACCCGGCAAAACAGGTAG-3′; loxp Rankl allele forward, 5′-CTGGGAGCGCAGGTTAAATA-3′ and reverse, and 5′-GCCAATAATTAAAATACTGCAGGAAA-3′. For bromodeoxyuridine (BrdU) administration, mice were given an i.p. injection of 100 mg BrdU/kg BW in Dulbecco's phosphate buffered saline (Gibco Laboratories) and were maintained on 1 mg/ml BrdU in the drinking water for 10 days before euthanasia. Amber bottles containing BrdU water were changed every 1 to 3 days.
Micro-CT analysis. We dissected femora and tibiae from mice free of soft tissue, fixed them overnight in 70% ethanol, and analyzed data by high-resolution μCT (SkyScan 1172, Bruker) (46, 59, 60) . The scanner was set at a voltage of 49 kV, a current of 200 μA, and a resolution of 8.7 μm/pixel. We used image reconstruction software (NRecon, v1.6, Micro Photonics), data analysis software (CTAn, v1.9, Bruker), and 3-dimensional model visualization software (μCT-Vol, v2.0, Bruker) to analyze the parameters of diaphyseal cortical bone and proximal tibia metaphyseal trabecular bone. We obtained cross-sectional images of the tibia to perform 2-dimensional morphometric analyses of cortical bone and 3-dimensional histomorphometric analysis of trabecular bone. The trabecular bone region of interest consisted of approximately 120 slices that were drawn starting from approximately 0.1 mm distal to the growth plate, constituting 0.7 mm in length. Trabecular bone was segmented from the bone marrow and analyzed to determine the trabecular bone volume fraction (BV/TV) and trabecular thickness. The region of interest of cortical analyses consisted of approximately 60 slices covering a length of 0.24 mm at the tibial midshaft. We analyzed cortical bone to determine cortical thickness and periosteal perimeter. For the analysis of periosteal microenvironment in the periosteal surface layer. Conditional ablation of PDGF-BB in macrophage-lineage TRAP + cells significantly reduced periostin expression in the periosteum ( Figure 6A ). Mechanistically, PDGF-BB upregulated periostin expression via inducing the phosphorylation of PDGFR-β, PI3K, AKT, and CREB. CREB is essential for enhanced osteogenic formation, which is modulated by PI3K/AKT signaling (55, 56) , but the downstream target of CREB in PDCs has not been well characterized. We showed that PDGF-BB could induce direct binding of pCREB to periostin promoter in ChIP assay. This finding reveals the mechanism by which periostin expression induced by TRAP + mononuclear cells maintains the periosteum microenvironment and regulates differentiation of PDCs for periosteum homeostasis and osteogenesis.
We sought to investigate the molecular and cellular mechanisms of periostin in regulating periosteal bone formation in adult mice. Because there are many types of cells in the periosteum, we chose to use PDCs, which cover a broad spectrum of cells from periosteum stem cells to their progenitors at different stages of differentiation. Periostin provides an osteogenic microenvironment and likely regulates osteoprogenitors, in addition to maintaining periosteum stem cells. Subsets of periosteal Nestin + cells and LepR + cells of PDCs were investigated. Nestin-GFP + PDCs are abundant in young mice with multidifferential potency and significantly decreased in adulthood (Figures 1 and 7 , and Supplemental Figures 1 and 10 mined when cortical bone and periosteum disappeared. We chose the medial sections as the selected plane, which enabled us to investigate the complete cortical bone and periosteum of the tibia. The slides were numbered to indicate the depth of the sections, and slides with comparable numbers from different groups were chosen to ensure that similar anatomical levels were compared. The diaphysis was defined to be a 1-mm section centered at the midpoint between the growth plate and the end of the tibia. We incubated the sections with primary antibodies to Nestin ). We used an LSM 780 FCS confocal microscope (Zeiss) or a BX51 microscope (Olympus) for imaging samples.
To examine dynamic bone formation, we subcutaneously injected 0.1% calcein (Sigma-Aldrich, 10 mg/kg BW) in phosphate-buffered saline into the mice 10 and 3 days before euthanasia. We observed calcein double-labeling in undecalcified bone slices under a fluorescence microscope to quantify mineralizing surfaces of periosteal, endosteal, and trabecular bone (MAR, μ/d; BFR/bone surface, μm . Briefly, we added cells with formaldehyde to cross-link proteins to DNA, and the cells were lysed in 1.5-ml lysis buffer (50 mM HEPES, pH 7.5, 140 mM NaCl; 1 mM EDTA; 1% Triton X-100; 0.1% sodium deoxy cholate; 0.1% sodium dodecyl sulfate). Cell lysates were sonicated at 2 seconds on/15 seconds off for 3 rounds using a Bioruptor ultrasonic cell disruptor (Diagenode) to shear genomic DNA to an average fragment size of 150 to 250 bp. Of the sample, 1% was removed for use as an input control. ChIP was performed according to the protocol provided by the Simple Chip Enzymatic Chromatin IP Kit (Cell Signaling Technology) using antibodies to pCREB (Cell Signaling Technology). Anti-RNA polymerase II and control IgG were used as positive and negative controls, respectively. After washing and de-crosslinking, the precipitated DNA was purified using a QIAquick PCR purification kit (Qiagen).
ChIP-quantitative PCR. ChIP-quantitative PCR (qPCR) was performed using SYBR green PCR Master Mix and 7900 HT Fast RealTime PCR System (Applied Biosystems). Primers for Frag 1, 2, and 3 of periostin were used (see Supplemental ) and xylazine (10 mg/kg -1 ). In addition, buprenorphine (0.05 mg/kg -1 ) was given for perioperative analgesia to minimize pain. Tibial cortical bone defects were created without penetrating the endosteal bone surface to exclude bone marrow progenitor cells and endosteal progenitor cells involved in periosteal cortical bone regeneration. Briefly, the anteromedial surfaces of the proximal one-third of the tibia were exposed by blunt dissection of the subcutaneous tissue after skin incision. The defect was generated using a 0.7-mm-diameter needle without penetrating the endosteal bone surface (drill depth, 0.5-0.6 mm). During drilling, a 5-ml syringe of normal saline was used to continuously flush away the bone debris. ) were then collected for flow cytometry. After the process of red blood cell lysis with commercial ammoniumchloride-potassium lysis buffer (Quality Biological), cells were then sorted according to side scatter and GFP and PDGFR-α expression or YFP expression after negative selection of CD45, CD31, and Ter119. FACS was performed using a 5-laser BD FACS and FACSDiva (BD Biosciences). Flow cytometric analyses were performed using a FACSCalibur flow cytometer, CellQuest software (BD Biosciences), and FlowJo software (Tree Star). The primary antibodies used were FITCconjugated anti-GFP (Abcam, ab290), APC mouse anti-mouse CD45.1 (BD Biosciences, 561873), APC rat anti-mouse CD31 (BD Biosciences, 561814), APC rat anti-mouse TER119 (BD Biosciences, 561033), PE rat anti-mouse CD140A (BD Biosciences, 562776), anti-PDGFR-β biotin (eBioscience, clone APB5, 1:200), anti-LepR-biotin (R&D Systems, BAF497), PerCP-conjugated anti-CD105 (BioLegend, CA 120415), and biotin anti-mouse CD90.2 (BioLegend, 105304).
Immunocytochemistry, immunofluorescence, and histomorphometry. At the time of euthanasia, mice tibiae were dissected and fixed with intact periosteum in 10% buffered formalin for 24 hours, decalcified in 10% EDTA (pH, 7.4) (Amresco) for 2 days, and embedded in paraffin or optimal cutting temperature compound (Sakura Finetek). We processed 4-μm-thick coronal (longitudinally) oriented sections of bone, including the metaphysis and diaphysis, for TRAP staining using a staining kit (MilliporeSigma). Immunofluorescence analysis of the bone sections was performed as described previously (6, 44) . Longitudinally oriented 30-μm-thick sections were cut from anterior to posterior for immunofluorescence staining. The first section was determined when the tibial tuberosity appeared and the last section was deter-jci. Statistics. Panels generally represent multiple independent experiments performed on different days with different mice. Data are presented as mean ± SEM unless otherwise stated. Unpaired, 2-tailed Student t tests were used for comparisons between 2 groups. For multiple comparisons, 1-way ANOVA with Bonferroni's post hoc test was applied. A P value less than 0.05 was deemed significant. All inclusion/ exclusion criteria were preestablished, and no samples or animals were excluded from the analysis. The investigators were blinded to allocation during the experiments and outcome assessments. Each animal was assigned an identification number using the animal's litter number in combination with the ear tag number. All data were normally distributed and had similar variation between groups. Statistical analysis was performed using SAS v9.3 software (SAS Institute).
Study approval. We maintained all animals in the animal facility of the Johns Hopkins University School of Medicine (Baltimore, Maryland, USA). The experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Johns Hopkins University.
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Preparing total RNA for qRT-PCR. Cells were sorted directly into TRIzol. Total RNA was extracted according to the manufacturer's instructions (Invitrogen). Total RNA was subjected to reverse transcription and then qRT-PCR using SYBR green on a LightCycler 480 (Roche). Primers used in this study are listed in Supplemental Table 2 .
In vitro assays for migration of PDCs. We assessed cell migration in 96-well Transwell plates (Corning) with 8- (bone marrow stromal cells sorted by certain cell markers as control). For CFU-F assays with sorted cells, we sorted cells directly into culture at a density of 10 cells/cm 2 in 6-well plates in 3 ml of α-MEM supplemented with glutamine (2 mM), penicillin (100 U/ml), streptomycin sulfate (100 μg/ml), and 20% lot-selected FBS, ensuring that colonies would form at clonal density to allow counting. After 2 to 3 hours of adhesion, unattached cells were removed. On day 10, we fixed and stained the cultures with 0.5% crystal violet. We counted the colonies that contained 50 cells or more. For in vitro differentiation of clonal CFU-F, individual cells were sorted into each well of 48-well plates and cultured for 14 days. Individual CFU-Fs were then digested with 0.25% trypsin/ EDTA, split into 3 aliquots, and subcloned into 3 separate cultures permissive for adipocyte, chondrocyte, and osteoblastic differentiation. of proline, and 20 ng/ml -1 of TGF-β3. After 3 weeks in culture, the pellets were fixed in 10% buffered formalin for 2 days and embedded in paraf-
